T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients
2011

T Regulatory Cells and Multiple Sclerosis

Sample size: 85 publication 10 minutes Evidence: moderate

Author Information

Author(s): Dacia Dalla Libera, Diletta Di Mitri, Alessandra Bergami, Diego Centonze, Claudio Gasperini, Maria Grazia Grasso, Simona Galgani, Vittorio Martinelli, Giancarlo Comi, Carlo Avolio, Gianvito Martino, Giovanna Borsellino, Federica Sallusto, Luca Battistini, Roberto Furlan

Primary Institution: Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy

Hypothesis

Are T regulatory cells involved in the activity of multiple sclerosis?

Conclusion

T regulatory cells are not responsible for causing relapses in multiple sclerosis but respond to inflammation to help restore balance.

Supporting Evidence

  • Tregs were significantly decreased in stable MS patients compared to healthy donors.
  • Treg levels were restored to normal during acute clinical attacks.
  • Markers of Tregs were significantly increased in patients experiencing a clinical relapse.

Takeaway

T regulatory cells help control inflammation in multiple sclerosis, and their levels change depending on whether a patient is stable or having a relapse.

Methodology

The study analyzed T regulatory cell markers in blood samples from multiple sclerosis patients using flow cytometry and real-time RT-PCR.

Limitations

The study was limited to peripheral blood samples, which may not fully represent T regulatory cell activity in the central nervous system.

Participant Demographics

Patients aged 18 to 52 with relapsing-remitting multiple sclerosis.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0021386

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication